Monday, May 23, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

RFI – Chemical Agent Countermeasure Support

by Global Biodefense Staff
May 14, 2015
Joint Project Manager Medical Countermeasure Systems

The DoD Medical Countermeasure Systems-Chemical Defense Pharmaceuticals (MCS-CDP) Joint Product Management Office  has a requirement to develop and deliver FDA licensed butyrylcholinesterase (BChE).

BChE is a bioscavenger prophylactic countermeasure against organophosphate nerve agents, binding nerve agent in the bloodstream before it can exert effects in the nervous system.

DynPort Vaccine Company LLC, a CSC company, is the prime contractor for this effort.

On behalf of DVC, the MCS-CDP JPMO is seeking interest by research or commercial entities with the capability to perform process development activities at small scale to intermediate scale in order to identify a source raw material and process to fit to the commercial scale requirements of this DoD contract.

Source raw material and historical manufacturing information will be provided by DVC.

Capability requirements include:

  • Acceptance of human plasma derived source material into the process development facility
  • Storage of the source material at -80OC (up to 50kg of starting source material per run)
  • Development and optimization of the purification process at the 1-5kg scale and 50kg scale
  • Manufacture and testing of an interim Reference Standard (RS) to support process development and optimization activities
  • Implementation of analytical methods to be used during process development and RS production effort, including but not limited to total protein, enzyme activity, and HPLC-based methods.
  • Project Management support including status meetings and monthly reports with technical, schedule and cost elements

In addition, the selected contractor must be able to meet a November 2015 down select of source material and process for commercial scale manufacturing.

Further details are available via Solicitation Number: W911QY-15-S-DAMD17.

Tags: AntitoxinsBioscavengersJPEO-CBRNDRFI

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

April 11, 2022
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs
Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

April 10, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC